European Journal of Biomedical and Pharmaceutical Sciences

ROLE OF SHATPUSHPA CHURNA IN INFERTILITY ANOVULATORY CYCLE

Jyoti B. Bhagile* and Vishnu Sonune

ABSTRACT

Fertility is the capacity of a couple to reproduce or the state of being fertile. Reproduction is the process that requires the interaction and the integrity of the female and male reproductive tracts. The couple who has not conceived after 12 months is the lowest reference limit for time to pregnancy (TTP) by the World Health Organization. Among the causes of infertility, ovarian factor overall contributes 20% and 15% in primary and secondary infertility respectively where as in females, it contributes 40%. Ovarian dysfunction encompasses anovulation or oligoovulation, corpus luteum insufficiency, luteinised unruptured follicle. Modern medical treatment for anovulation i.e. failure to produce mature ovum includes hormonal therapy, In Vitro Fertilization (IVF), Embryo Transfer (ET), Gamete Intra Fallopian Transfer (GIFT) etc., but they have unsatisfactory results, enormous expenses and lots of side effects like ovarian hyper stimulation, frequent abortion, multiple gestations and major long term possibility of ovarian cancer. There is a need of time to evaluate some alternative medicine in infertility due to anovulation. While referring the Samhitas, the single drug found which can be helpful in such cases is Shatpushpa. Indication of use of Shatpushpa given in Kashyapsamhita directly points out its utility in ovulatory dysfunction. To ascertain effectiveness of Shatpushpa, an attempt was made by reviewing previous research works which were carried out in anovulatory factor of infertility with the use of Shatpushpa in different dosage forms.

Keywords: .